Edmond de Rothschild Asset Management (France)’s Ionis Pharmaceuticals IONS Stock Holding History

Edmond de Rothschild Asset Management (France)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$6.59M	Sell	180,000 -20,000	-10%	-$626K	0.29%	81
2016 Q2	$4.66M	Hold	200,000	–	–	0.21%	94
2016 Q1	$8.1M	Hold	200,000	–	–	0.35%	78
2015 Q4	$12.4M	Sell	200,000 -38,000	-16%	-$2.05M	0.44%	66
2015 Q3	$9.62M	Buy	238,000 +37,300	+19%	+$1.93M	0.32%	75
2015 Q2	$11.6M	Buy	+200,700	New	+$12.8M	0.31%	77

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Edmond de Rothschild Asset Management (France)'s IONS Position: Q3 2016 in Review

Edmond de Rothschild Asset Management (France) reduced its Ionis Pharmaceuticals (IONS) stake by 10% in Q3 2016, selling an estimated $626K and leaving 180,000 shares worth $6.59M. The position accounts for 0.29% of the portfolio, ranked #81.

Edmond de Rothschild Asset Management (France) first reported a position in IONS in Q2 2015 and has held it in 6 quarters since. The position peaked at $12.4M in Q4 2015. 282 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

Edmond de Rothschild Asset Management (France) held 180,000 shares of Ionis Pharmaceuticals worth $6.59M as of Q3 2016.
Edmond de Rothschild Asset Management (France) sold 20,000 Ionis Pharmaceuticals shares in Q3 2016, an estimated $626K.
Ionis Pharmaceuticals made up 0.29% of Edmond de Rothschild Asset Management (France)'s portfolio in Q3 2016, its #81 holding.
Edmond de Rothschild Asset Management (France) first reported a position in Ionis Pharmaceuticals in Q2 2015 and has held it in 6 quarters since.
Edmond de Rothschild Asset Management (France)'s Ionis Pharmaceuticals position peaked at $12.4M in Q4 2015.
282 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q3 2016, filed 14 Nov 2016.